Direct to Site Distribution

Direct to Site Distribution

For Open Label studies, CSI can deliver directly to sites in a fast, reliable, and cost-effective manner.

We work closely with project managers; we assist with the trial forecast and ensure medication is available at the sites as needed. This is a particularly attractive way of supplying to clinical trials. Supplying expensive oncology products and minimising wastage is of great importance.

In addition, patient recruitment dictates what medication is required at sites. Our flexible and adaptive solutions ensure that we can deliver fast all over the world and no patient is turned down due to lack of medication.